The treatment has been shown to be active against third generation cephalosporin-resistant Enterobacterales species. Orlynvah combines sulopenem etzadroxil, a penem antibacterial drug, and probenecid, ...
The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Pharmacists will be able to hand out antibiotics for urinary tract infections from Monday, marking the first condition included in a push to expand pharmacy services across the Northern Territory.